Ardent Health Partners PT Raised to $21 at Mizuho
Moderately bullish on the target increase, with limited evidence beyond the analyst view.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Moderately bullish on the target increase, with limited evidence beyond the analyst view.
What happened, with direct paths to the underlying reporting
Mizuho raised its price target to $21, about 17% above the posted price of $17.93. The target is an analyst opinion.
Target: $21
Posted price: $17.93
Analyst firm: Mizuho Securities
Analyst: Ann Hynes
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.